NEXTGEN VC PODCAST

Empowering Venture Capital Associates

Anna French on Building Qiming in the States and the Global Future of Biotech

Featured Guest

  • Anna French, D.Phil, Managing Partner, Qiming Venture Partners US

    Anna French, D.Phil, Managing Partner, Qiming Venture Partners US

    Anna French, D.Phil., is a Managing Partner at Qiming Venture Partners US (Qiming US). She joined the firm in 2017 and currently serves on the boards of Umoja Biopharma, Empirico Inc., Renasant Bio, Auron Therapeutics, Entact Bio, and several stealth company incubations. Additionally, she led Qiming’s investment in Cadent Therapeutics (acquired by Novartis) and Jasper Therapeutics (NASDAQ:JSPR).

     

    Anna joined Qiming US from the Boston Consulting Group (BCG), where she was a healthcare management consultant advising leading pharmaceutical and biotech companies on their strategy and operations, with a focus on advanced therapies. Previously, she led a global industry-academic consortium centered on cell therapy commercialization, the Centre for the Advancement of Sustainable Medical Innovation (CASMI)’s Translational Stem Cell Consortium, a partnership between Oxford University and University College London.

     

    Anna earned a D.Phil. from the University of Oxford, UK, where her research focused on the hematological differentiation of human-induced pluripotent stem cells. She has authored over 20 publications in the field of stem cell research. Anna received her BSc in Biochemistry with first class honors from the University of Bristol.

On This Episode

Dr. Anna French, Managing Partner at Qiming Venture Partners USA, joins the NextGen VC Podcast to trace her nonlinear path from an Oxford DPhil and BCG boardrooms to becoming employee #1 at one of biotech’s most globally connected venture firms.

Anna shares what it’s really like to build a fund from the ground up, why she championed Umoja Biopharma’s bold bet on in vivo CAR-T and in-house manufacturing, and how a global perspective — forged in UK labs, Korean hospitals, and Parisian roundtables — shapes the way she looks for innovation. She shares candidly about LP fundraising, the US-China biotech opportunity, and what work-life balance actually looks like when both you and your spouse are running full speed.


This episode may feature current or former clients of Wilson Sonsini. This podcast is for general informational purposes and is not intended to provide and should not be relied on as legal advice. The information in this podcast is not tailored to a particularized situation or jurisdiction, may not reflect the current state of the law, and should not be considered a substitute for the advice of your own legal counsel. You should not consider this podcast an invitation to form an attorney-client relationship, and no attorney-client relationship is created by your use of this podcast. Wilson Sonsini disclaims all liability in respect to any actions taken or not taken based on the content of this podcast and notes that prior results do not guarantee a similar outcome. This podcast may be considered attorney advertising in certain jurisdictions.

Meet the Hosts

Mike Hostetler LaunchBio

Michael Hostetler, JD, PhD - Partner, Wilson Sonsini

Mike is a partner in the San Francisco (SoMa) and San Diego offices of Wilson Sonsini Goodrich & Rosati. He has provided strategic intellectual property counseling to hundreds growth enterprises in the pharmaceutical and biotechnology industries, both venture-backed and public companies. His expertise includes patent strategy, prosecution, and diligence (both buy and sell side) for venture financings, public offerings, mergers and acquisitions.

Jennifer Fang, MEng, JD, Partner, Wilson Sonsini Goodrich & Rosati

Jennifer Fang, JD, M.Eng. - Partner, Wilson Sonsini

Jennifer is a partner in the Boston office of Wilson Sonsini Goodrich & Rosati. She helps innovative startups grow into successful enterprises by providing counsel to the founders, management teams and boards and by handling the legal and strategic business issues and transactions that arise at each stage. She is a member of the National Venture Capital Association (NVCA) General Counsel Advisory Board and is a frequent speaker.

All Episodes

Sponsor

Powered by LaunchBio with generous support from Wilson Sonsini